Prognoses for acute promyelocytic leukemia (APL) patients improved drastically upon the introduction of differentiation therapy with all-trans-retinoic acid (ATRA) in combination with conventional chemotherapy. Unfortunately, this therapeutic approach has not translated to other genetic subtypes of acute myeloid leukemia...

External Link:

https://ashpublications.org/blood/article/128/22/5206/99967/Ex-Vivo-High-Throughput-Flow-Cytometry-Screening